4
Changes in Ownership
Gain Therapeutics, Inc. Filed Acc 0001209191-22-051003
Options or other derivatives
- Chief Operating Officer acquired 71,100 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Alder Matthias Chief Operating Officer | 2022-09-20 | Grant or award · Employee Stock Option (right to buy) | +60,900 | 60,900 | D | ||
| Alder Matthias Chief Operating Officer | 2022-09-20 | Grant or award · Restricted Stock Units | +10,200 | 10,200 | D | ||
Loading xslF345X03/doc4.xml…